Publication - 2026Beyond Pigment Loss: Three Therapeutic Objectives in Vitiligo

Publication

Beyond Pigment Loss: Three Therapeutic Objectives in Vitiligo

Vitiligo entails three therapeutic objectives: control of autoimmune activity, restoration of melanocyte function, and interruption of disease memory. Distinguishing these goals can refine clinical management, trial endpoints, and therapeutic development in vitiligo and other immune-mediated skin diseases.


Published in: International Journal of Dermatology

Date: 15 September 2026


 

Beyond Pigment Loss: Three Therapeutic Objectives in Vitiligo   

Yan Valle, Torello Lotti, Julia Sigova, Davinder Parsad



FAQOther Questions

  • Vitiligo and hearing loss: any connection?

    Vitiligo is primarily recognized for causing skin discoloration, but it can also impact melanocytes in unexpected areas, such as the inner ear. This raises questions about wheth...

  • Vitiligo and Pregnancy

    VRF Frequently Asked Questions Vitiligo and Pregnancy Pregnancy, treatments, inheritance, fertility and the questions people usually remember to ask five minutes after leaving t...

  • What are the best predictors for therapy response in vitiligo?

    A fair question. Also a slightly annoying one, because dermatology loves nuance and patients usually want something more like a weather forecast. Still, a few factors do show up...